Abstract
The role of mixed infections with different hepatitis C virus (HCV) genotypes in viral persistence, treatment effects, and tissue tropism is unclear. Next-generation sequencing (NGS), which is suitable for analysis of large, genetically diverse populations offers unparalleled advantages for the study of mixed infections. The aim of the study was to determine, using two different deep sequencing strategies (pyrosequencing – 454 Life Sciences/Roche and reversible terminator sequencing-by-synthesis by Illumina), the origin of a novel HCV genotype transiently detectable during antiviral therapy (pre-existing minor population vs. de novo superinfection). Secondly, we compared 5′ untranslated region (5′-UTR) variants obtained by the two NGS approaches. 5′ UTR amplification products from 9 samples collected from genotype 1b infected patient before, during, and after treatment (4 serum and 5 peripheral blood mononuclear cell – PBMC – samples) were subjected to the next-generation sequencing. The sequencing revealed the presence of two (454/Roche) and one (Illumina) genotype 4 variants in PBMC at Week 16. None of these variants were present either in the preceding or following samples as revealed by both platforms. 454/Roche sequencing detected 24 different 5’-UTR variants: 8 were present in serum and PBMC, 4 only in serum and 12 only in PBMC. Illumina sequencing detected 11 different 5’-UTR variants: 5 in serum and PBMC, 4 only in serum and 2 only in PBMC. Six variants were identical for both sequencing platforms. The difference in variants number was primarily due to variability in two 5’-UTR homopolymeric regions. In conclusion, longitudinal analysis of HCV variants, employing two independent deep sequencing methods, suggests that the transient presence of a different genotype strain in PBMC was a result of superinfection and not a selection of pre-existing minor variant.
This is a preview of subscription content, log in via an institution.
References
Barzon L, Lavezzo E, Militello V, Toppo S, Palu G (2011) Applications of next-generation sequencing technologies to diagnostic virology. Int J Mol Sci 12(11):7861–7884
Blackard JT (2012) HCV superinfection and reinfection. Antivir Ther 17(7 Pt B):1443–1448
Blackard JT, Sherman KE (2007) Hepatitis C virus coinfection and superinfection. J Infect Dis 195(4):519–524
Bowden S, McCaw R, White PA, Crofts N, Aitken CK (2005) Detection of multiple hepatitis C virus genotypes in a cohort of injecting drug users. J Viral Hepat 12(3):322–324
Buoro S, Pizzighella S, Boschetto R, Pellizzari L, Cusan M, Bonaguro R, Mengoli C, Caudai C, Padula M, Egisto VP, Palu G (1999) Typing of hepatitis C virus by a new method based on restriction fragment length polymorphism. Intervirology 42(1):1–8
Cai Q, Zhao Z, Liu Y, Shao X, Gao Z (2013) Comparison of three different HCV genotyping methods: core, NS5B sequence analysis and line probe assay. Int J Mol Med 31(2):347–352
Fan X, Lang DM, Xu Y, Lyra AC, Yusim K, Everhart JE, Korber BT, Perelson AS, Di Bisceglie AM (2003) Liver transplantation with hepatitis C virus-infected graft: interaction between donor and recipient viral strains. Hepatology 38(1):25–33
Forton DM, Karayiannis P, Mahmud N, Taylor-Robinson SD, Thomas HC (2004) Identification of unique hepatitis C virus quasispecies in the central nervous system and comparative analysis of internal translational efficiency of brain, liver, and serum variants. J Virol 78(10):5170–5183
Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Goncales FL Jr, Haussinger D, Diago M, Carosi G, Dhumeaux D, Craxi A, Lin A, Hoffman J, Yu J (2002) Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 347(13):975–982
Gilles A, Meglecz E, Pech N, Ferreira S, Malausa T, Martin JF (2011) Accuracy and quality assessment of 454 GS-FLX Titanium pyrosequencing. BMC Genomics 12:245
Horiike N, Masumoto T, Michitaka K, Kurose K, Akbar SM, Onji M (1996) Response to interferon in chronic hepatitis C due to mixed genotype infection. J Gastroenterol Hepatol 11(4):353–357
Idrees M, Ur RI, Manzoor S, Akbar H, Butt S, Afzal S, Yousaf MZ, Hussain A (2011) Evaluation of three different hepatitis C virus typing methods for detection of mixed-genotype infections. J Dig Dis 12(3):199–203
Kircher M, Sawyer S, Meyer M (2012) Double indexing overcomes inaccuracies in multiplex sequencing on the Illumina platform. Nucleic Acids Res 40(1), e3
Laskus T, Wang LF, Rakela J, Vargas H, Pinna AD, Tsamandas AC, Demetris AJ, Fung J (1996) Dynamic behavior of hepatitis C virus in chronically infected patients receiving liver graft from infected donors. Virology 220(1):171–176
Laskus T, Radkowski M, Wang LF, Nowicki M, Rakela J (2000) Uneven distribution of hepatitis C virus quasispecies in tissues from subjects with end-stage liver disease: confounding effect of viral adsorption and mounting evidence for the presence of low-level extrahepatic replication. J Virol 74(2):1014–1017
Laskus T, Wang LF, Radkowski M, Nowicki M, Wilkinson J, Rakela J (2001) Exposure of hepatitis C virus-negative recipients to > or =2 infected blood donors. J Infect Dis 183(4):666–669
Liang B, Luo M, Scott-Herridge J, Semeniuk C, Mendoza M, Capina R, Sheardown B, Ji H, Kimani J, Ball BT, Van Domselaar G, Graham M, Tyler S, Jones SJ, Plummer FA (2011) A comparison of parallel pyrosequencing and sanger clone-based sequencing and its impact on the characterization of the genetic diversity of HIV-1. PLoS One 6(10), e26745
Nakatani SM, Santos CA, Riediger IN, Krieger MA, Duarte CA, do Carmo Debur M, Carrilho FJ, Ono SK (2011) Comparative performance evaluation of hepatitis C virus genotyping based on the 5’ untranslated region versus partial sequencing of the NS5B region of brazilian patients with chronic hepatitis C. Virol J 8:459
Otto TD, Sanders M, Berriman M, Newbold C (2010) Iterative Correction of Reference Nucleotides (iCORN) using second generation sequencing technology. Bioinformatics 26(14):1704–1707
Quail MA, Smith M, Coupland P, Otto TD, Harris SR, Connor TR, Bertoni A, Swerdlow HP, Gu Y (2012) A tale of three next generation sequencing platforms: comparison of Ion Torrent, Pacific Biosciences and Illumina MiSeq sequencers. BMC Genomics 13:341
Ramirez S, Perez-del-Pulgar S, Carrion JA, Coto-Llerena M, Mensa L, Dragun J, Garcia-Valdecasas JC, Navasa M, Forns X (2010) Hepatitis C virus superinfection of liver grafts: a detailed analysis of early exclusion of non-dominant virus strains. J Gen Virol 91(Pt 5):1183–1188
Roque-Afonso AM, Ducoulombier D, Di Liberto G, Kara R, Gigou M, Dussaix E, Samuel D, Feray C (2005) Compartmentalization of hepatitis C virus genotypes between plasma and peripheral blood mononuclear cells. J Virol 79(10):6349–6357
Schroter M, Feucht HH, Zollner B, Schafer P, Laufs R (2003) Multiple infections with different HCV genotypes: prevalence and clinical impact. J Clin Virol 27(2):200–204
Simen BB, Simons JF, Hullsiek KH, Novak RM, Macarthur RD, Baxter JD, Huang C, Lubeski C, Turenchalk GS, Braverman MS, Desany B, Rothberg JM, Egholm M, Kozal MJ, Terry Beirn A, Community Programs for Clinical Research on AIDS (2009) Low-abundance drug-resistant viral variants in chronically HIV-infected, antiretroviral treatment-naive patients significantly impact treatment outcomes. J Infect Dis 199(5):693–701
Simmonds P, Alberti A, Alter HJ, Bonino F, Bradley DW, Brechot C, Brouwer JT, Chan SW, Chayama K, Chen DS et al (1994) A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 19(5):1321–1324
Sole M, Pellerin M, Malnou CE, Dhumeaux D, Kean KM, Pawlotsky JM (2002) Quasispecies heterogeneity and constraints on the evolution of the 5’ noncoding region of hepatitis C virus (HCV): relationship with HCV resistance to interferon-alpha therapy. Virology 298(1):160–173
Stuyver L, Wyseur A, van Arnhem W, Lunel F, Laurent-Puig P, Pawlotsky JM, Kleter B, Bassit L, Nkengasong J, van Doorn LJ et al (1995) Hepatitis C virus genotyping by means of 5’-UR/core line probe assays and molecular analysis of untypeable samples. Virus Res 38(2–3):137–157
Tamura K, Nei M (1993) Estimation of the number of nucleotide substitutions in the control region of mitochondrial DNA in humans and chimpanzees. Mol Biol Evol 10(3):512–526
Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S (2011) MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 28(10):2731–2739
Tuveri R, Rothschild C, Pol S, Reijasse D, Persico T, Gazengel C, Brechot C, Thiers V (1997) Hepatitis C virus genotypes in French haemophiliacs: kinetics and reappraisal of mixed infections. J Med Virol 51(1):36–41
Zuker M (2003) Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res 31(13):3406–3415
Acknowledgements
This work was supported by the projects from Polish National Science Center NN 401646740 and 1 M24/PM12/12.
Conflicts of Interest
The authors declare no conflicts of interest in relation to this article.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Caraballo Cortes, K. et al. (2015). Next-Generation Sequencing of 5′ Untranslated Region of Hepatitis C Virus in Search of Minor Viral Variant in a Patient Who Revealed New Genotype While on Antiviral Treatment. In: Pokorski, M. (eds) Respirology. Advances in Experimental Medicine and Biology(), vol 885. Springer, Cham. https://doi.org/10.1007/5584_2015_186
Download citation
DOI: https://doi.org/10.1007/5584_2015_186
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-25851-5
Online ISBN: 978-3-319-25853-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)